Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT01076751
Brief Summary:
Primary Objective:
* Describe real-life survival of CRPC patients who received first-line docetaxel and have disease progression
Secondary Objective:
* Describe treatment patterns
* Describe the characteristics and outcomes of patients who received second-line taxane-based treatment compared to others
* Describe economic and patient-reported outcomes
Study:
NCT01076751
Study Brief:
Protocol Section:
NCT01076751